Canaccord Genuity Group Trims Progyny (NASDAQ:PGNY) Target Price to $18.00

Progyny (NASDAQ:PGNY – Free Report) had its target price decreased by Canaccord Genuity Group from $24.00 to $18.00 in a research note published on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a hold rating on the stock. PGNY has been the topic of a number of other reports. JPMorgan Chase & Co. decreased […]

Leave a Reply

Your email address will not be published.

Previous post Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Consensus Rating of “Moderate Buy” from Analysts
Next post Progyny (NASDAQ:PGNY) PT Lowered to $24.00